Concepedia

Author

Tania Crombet

Center of Molecular Immunology (Cuba)ORCID

Also Known As

Crombet T, Crombet Tania, Crombet, Tania, Nuris Ledón, T Crombet, T. Crombet, T. Crombet Ramos, T. Crombet-Ramos, T.C.F. Ramos, Tania Crombet

200

Publications

4.7K

Citations

35

H-Index

77

Concepts

All Affiliations

Center of Molecular Immunology (Cuba)Hermanos Ameijeiras HospitalHospital Oncológico Docente "Conrado Benítez García"Instituto de Oncología y RadiobiologíaCuban Neuroscience Center
TC

About

Tania Crombet is an author at Center of Molecular Immunology (Cuba) specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

27

1.8K

2

Cell Biology

5

5

813

3

Health Sciences

2

2

42

4

Public Health

1

1

27

5

Clinical Immunology

1

1

10

Tania Crombet

×

58

Publications

3.9K

Citations

31

H-Index

YearCitations

Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis.

Alicia Viloria‐Petit, Tania Crombet, S Jothy,

PubMed

2001

557

Use of the Humanized Anti-Epidermal Growth Factor Receptor Monoclonal Antibody h-R3 in Combination With Radiotherapy in the Treatment of Locally Advanced Head and Neck Cancer Patients

Tania Crombet, Marta Osorio, Teresa Cruz,

Journal of Clinical Oncology

2004

298

Phase II Randomized Controlled Trial of an Epidermal Growth Factor Vaccine in Advanced Non–Small-Cell Lung Cancer

Elia Nenínger Vinageras, Ana de la Torre, Marta Osorio Rodríguez,

Journal of Clinical Oncology

2008

200

Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck

Marta Osorio Rodríguez, Teresa Rivero, R. Bahi,

Cancer Biology & Therapy

2010

167

Antiproliferative, antiangiogenic and proapoptotic activity of h‐R3: A humanized anti‐EGFR antibody

Tania Crombet, Janusz Rak, Rolando Pérez,

International Journal of Cancer

2002

166

A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

Pedro C. Rodríguez, Xitllaly Popa, Odeth Martínez,

Clinical Cancer Research

2016

163

Treatment of high-grade glioma patients with the humanized anti-epidermal growth factor receptor (EGFR) antibody h-R3: Report from a phase I/II trial

Tania Crombet, Javier Figueredo, Mauricio Catalá,

Cancer Biology & Therapy

2006

161

A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial

Gabriela Gonzalez, Tania Crombet, Mauricio Catalá,

Annals of Oncology

1998

154

Bivalent binding by intermediate affinity of nimotuzumab: A contribution to explain antibody clinical profile

Greta Garrido, Ilia Tikhomirov, Ailem Rabasa,

Cancer Biology & Therapy

2011

149

A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

Anet Valdés-Zayas, Eduardo R. Santiesteban, Yoanna I. Flores,

Clinical Cancer Research

2014

126

Page 1